22.5 C
New York
Wednesday, June 17, 2026

Tag: competition

newssourceFORcompanyinformationcontent1marketreleases

POLARIS SWEEPS BAJA 500 UTV OVERALL PODIUM AS BRANDEN SIMS CLAIMS VICTORY

Sims Leads All-Polaris Podium, Followed by Wayne Matlock in Second and First-Year RZR Factory Racing Driver Ethan Groom in Third Polaris Locks Out Top...

Electrolytic Manganese Dioxide (EMD) Market to Reach USD 1.45 Billion by 2032 Amid Battery Demand Growth | Valuates Reports

BANGALORE, India, June 9, 2026 /PRNewswire/ -- ...

Electrolytic Manganese Dioxide (EMD) Market to Reach USD 1.45 Billion by 2032 Amid Battery Demand Growth | Valuates Reports

BANGALORE, India, June 9, 2026 /PRNewswire/ -- ...

SONIFI showcases how hotels can set a new standard with their guest technology and managed services at HITEC 2026

LOS ANGELES, June 9, 2026 /PRNewswire/ -- Hospitality's largest global guest technology managed services provider, SONIFI, is unveiling its latest innovations at the annual...

Fusion Fuel Shareholders Approve All Proposed Resolutions, Including Potentially Transformational Royal Uranium Acquisition

Royal Uranium Approval Expected to Advance Company's Potential Transformation into a Diversified Energy Platform

10th Huawei ICT Competition Concludes with Student Winners from 49 Countries and Regions and a Record 220,000 Participants

SHENZHEN, China, June 9, 2026 /PRNewswire/ -- The Closing & Awards Ceremony of the 10th Huawei ICT Competition Global Final was held today in...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

EASTERN PLATINUM LIMITED ANNOUNCES DISMISSAL OF CASES

VANCOUVER, BC, June 9, 2026 /CNW/ - Eastern Platinum Limited (TSX: ELR) (JSE: EPS) ("Eastplats" or the "Company") is pleased to announce that the...

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., June 8, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common...

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 8, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

Mission Produce® Announces Fiscal 2026 Second Quarter Financial Results

Acquisition of Calavo Growers completed May 28, 2026

Reborn Coffee Appoints Jung Jae Lim to Assume Full Responsibilities as Chief Executive Officer as Part of Natural Leadership Transition

Reborn Coffee Appoints Jung Jae Lim to Assume Full Responsibilities as Chief Executive Officer as Part of Natural Leadership Transition

Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer

FLOWER MOUND, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX) announces that on June 3, 2026, Yasir Haider was appointed Chief Financial Officer of Mannatech, Incorporated (the "Company").

Shell plc Commences Registered Exchange Offers for Notes Issued in Connection with Prior Private Exchange Offer by Shell Finance US Inc.

Press Release

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompetition

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers